{"slideshow_credits": null, "snippet": "The pharmaceutical giant Allergan rejected Valeant\u2019s nearly $50 billion bid, saying it could pursue its own acquisitions of other drug companies.", "abstract": "The pharmaceutical giant Allergan rejected Valeant\u2019s nearly $50 billion bid, saying it could pursue its own acquisitions of other drug companies.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}], "original": "By DAVID GELLES"}, "web_url": "http://dealbook.nytimes.com/2014/05/12/allergan-formally-rejects-valeants-merger-bid/", "lead_paragraph": null, "headline": {"main": "In Rejecting Merger Bid, Allergan Focuses on Strategy", "print_headline": "In Rejecting Merger Bid, Allergan Focuses on Strategy", "kicker": "DealBook"}, "_id": "5370bab638f0d8044e0ea463", "word_count": "955", "multimedia": [{"height": 126, "url": "images/2014/05/13/business/dbpix-botox-3/dbpix-botox-3-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/05/13/business/dbpix-botox-3/dbpix-botox-3-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 412, "url": "images/2014/05/13/business/dbpix-allergan3/dbpix-allergan3-articleLarge.jpg", "legacy": {"xlarge": "images/2014/05/13/business/dbpix-allergan3/dbpix-allergan3-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "412"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/05/13/business/dbpix-botox-3/dbpix-botox-3-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/05/13/business/dbpix-botox-3/dbpix-botox-3-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-05-12T08:11:39Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Ackman, William A", "rank": "1"}, {"name": "organizations", "value": "Pershing Square Capital Management", "rank": "2"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "rank": "3"}, {"name": "organizations", "value": "Allergan Inc", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}